Serum samples collected at week 4 were examined by pseudo-neutralization assay. For separate inoculation experiments, mice (n = 4 per group) were immunized intramuscularly with Trivalent-1, Separate 16, Separate 18, Separate 58 and corresponding monovalent

vaccines, respectively. Trivalent-1 vaccine and monovalent vaccines were inoculated at one site, while “Separate” SAR405838 vaccines were inoculated at two sites. “Separate 16” indicated that HPV 16 L1 VLPs were injected at left leg separately, while HPV 18 L1 VLPs and HPV 58 L1 VLPs were mixed and injected at right leg. “Separate 18” meant that HPV 18 L1 VLPs were injected at left leg, while other two types at right leg. “Separate 58” also had similar meaning. Serum samples were collected at week 4 and 6 and detected by pseudo-neutralization assay. Production of pseudoviruses were produced according to previous studies [34], [35] and [36]. To be specific, 293TT cells (provided by Prof. John Schiller) were co-transfected with L1, L2 expression vectors (p16SHELL and p18SHELL, provided by Prof. John Schiller; p58SHELL, provided Staurosporine concentration by Prof. Tadahito Kanda) and reporting plasmid (pEGFP-N1, Clonetech). Cells were harvested 48 h after transfection, lysed with cell lysis buffer [0.5% Brij58 (Sigma–Aldrich), 0.2% Benzonase (Merck), 0.2% Plasmid Safe ATP-Dependent DNase (EPICENTRE

Biotechnologies) DPBS-Mg solution], and incubated at 37 °C for 24 h. The cell lysate was extracted with 5 M NaCl solution, and then examined for the titers. The titers of pseudoviruses were defined as the dilution factors at TCID50 (tissue culture infective dose). 2000 TCID50/50 μl pseudoviruses were determined as the inoculating dose for neutralization assay. 293TT cells were incubated at 37 °C in 96-well plate at a density of 1.5 × 104 cells per well for 6 h. Sera were diluted according to a 5-fold dilution. Pseudoviruses were diluted to 2000 TCID50/50 μl. 60 μl pseudoviruses diluent and 60 μl serially diluted sera were mixed thoroughly and incubated at 4 °C for 1 h in a dilution plate. The negative

control was prepared by mixing of 60 μl pseudoviruses diluent and 60 μl culture media. 100 μl of mixture per well were added to the cell culture plate and incubated at 37 °C CYTH4 for 72 h. Cells were digested with trypsinase and transferred to cell sorting tube. The fluorescent cells were detected by FACS (fluorescence activated cell sorting). The percent infection inhibition was calculated with following formula: Percent infection inhibition (%)=1−the proportion of fluorescent cells in the sera incubated samplethe proportion of fluorescent cells in the negative control sample×100 The endpoint titers were calculated as the base 10 logarithm of the highest sera dilution with percent infection inhibition higher than 50%.